Caribou Biosciences Inc

NASDAQ:CRBU   11:08:08 AM EDT
8.15
+0.12 (+1.49%)
Earnings Announcements

Caribou Biosciences Reports Fourth Quarter Loss Per Share Of $0.31

Published: 03/21/2022 20:14 GMT
Caribou Biosciences Inc (CRBU) - Caribou Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update.
Caribou Biosciences Inc - Had $413.5 Million in Cash, Cash Equivalents, and Marketable Securities As of December 31, 2021.
Caribou Biosciences Inc Qtrly Loss per Share $0.31.
Caribou - Cash, Cash Equivalents, Marketable Securities As of Dec 31, 2021 Support Advancement of Allogeneic Car-t and Car-nk Cell Therapies.
Revenue is expected to be $2.86 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $3.54 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.